Literature DB >> 19623672

The excess burden of stroke in hospitalized adults with sickle cell disease.

John J Strouse1, Lori C Jordan, Sophie Lanzkron, James F Casella.   

Abstract

This report compares the relative rates and risk factors associated with stroke in adults versus children with sickle cell disease (SCD) in the United States over the last decade. We identified incident strokes in patients with SCD using ICD-9 codes for acute stroke and SCD and the California Patient Discharge Databases. We estimated SCD prevalence by using the incidence of SCD at birth with adjustment for early mortality from SCD. We identified 255 acute strokes (70 primary hemorrhagic and 185 ischemic) among 69,586 hospitalizations for SCD-related complications from 1998 to 2007. The rate of stroke in children [<18 years old (310/100,000 person-years)] was similar to young adults [18-34 years old (360/100,000 person-years)], but much higher in middle-aged [35-64 years old (1,160/100,000 person-years)] and elderly adults [> or =65 years old (4,700/100,000 person-years)]. Stroke was associated with hypertension in children and hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, and renal disease in adults. Most acute strokes (75%) and in-hospital deaths from stroke (91%) occurred in adults. Our results suggest that the rate of stroke in SCD peaks in older adults and is three-fold higher than rates previously reported in African-Americans of similar age (35-64 years) without SCD. Stroke in SCD is associated with several known adult risk factors for ischemic and hemorrhagic stroke. Studies for the primary and secondary prevention of stroke in adults with SCD are urgently needed. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19623672      PMCID: PMC2737603          DOI: 10.1002/ajh.21476

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  35 in total

Review 1.  Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.

Authors:  K Ohene-Frempong
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

2.  The natural history of stroke in sickle cell disease.

Authors:  D Powars; B Wilson; C Imbus; C Pegelow; J Allen
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

Review 3.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Authors:  Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Craig S Anderson
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

4.  Declining stroke rates in Californian children with sickle cell disease.

Authors:  Heather J Fullerton; Robert J Adams; Shoujun Zhao; S Claiborne Johnston
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

5.  Stroke in a cohort of patients with homozygous sickle cell disease.

Authors:  B Balkaran; G Char; J S Morris; P W Thomas; B E Serjeant; G R Serjeant
Journal:  J Pediatr       Date:  1992-03       Impact factor: 4.406

6.  Risk of stroke in children: ethnic and gender disparities.

Authors:  Heather J Fullerton; Yvonne W Wu; Shoujun Zhao; S Claiborne Johnston
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

7.  Stroke in a biracial population: the excess burden of stroke among blacks.

Authors:  Brett Kissela; Alexander Schneider; Dawn Kleindorfer; Jane Khoury; Rosemary Miller; Kathleen Alwell; Daniel Woo; Jerzy Szaflarski; James Gebel; Charles Moomaw; Arthur Pancioli; Edward Jauch; Rakesh Shukla; Joseph Broderick
Journal:  Stroke       Date:  2004-02       Impact factor: 7.914

Review 8.  Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis.

Authors:  N M Oyesiku; D L Barrow; J R Eckman; S C Tindall; A R Colohan
Journal:  J Neurosurg       Date:  1991-09       Impact factor: 5.115

9.  High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.

Authors:  W C Wang; E H Kovnar; I L Tonkin; R K Mulhern; J W Langston; S W Day; M J Schell; J A Wilimas
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

10.  Periodic transfusions for sickle cell anemia and CNS infarction.

Authors:  S Sarnaik; D Soorya; J Kim; Y Ravindranath; J Lusher
Journal:  Am J Dis Child       Date:  1979-12
View more
  22 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

2.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

Review 3.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

Review 4.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

5.  Bleeding in patients with sickle cell disease: a population-based study.

Authors:  Nisha Hariharan; Ann Brunson; Anjlee Mahajan; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2020-03-10

Review 6.  Chronic organ failure in adult sickle cell disease.

Authors:  Elliott Vichinsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 7.  Sickle Cell Disease and Stroke: Diagnosis and Management.

Authors:  Courtney Lawrence; Jennifer Webb
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

8.  Sickle cell disease in California: sociodemographic predictors of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Rachna Khanna; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

9.  Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis.

Authors:  Kemar V Prussien; Lori C Jordan; Michael R DeBaun; Bruce E Compas
Journal:  J Pediatr Psychol       Date:  2019-09-01

10.  National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.

Authors:  Timothy L McCavit; Lei Xuan; Song Zhang; Glenn Flores; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2012-11-14       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.